Der indkom i alt 12 ansøgninger vedrørende bioteknologisk afledte lægemidler (del A) og 33 ansøgninger vedrørende innovative lægemidler (del B).
A total of 12 applications were made for biotechnology medicinal products falling under Part A of the Annex and 33 applications for innovative medicines falling under Part B.